Just hot air? We are still waiting on results for five years now.
Demis Hassabis is the CEO.
"... Isomorphic Labs is an offshoot of Alphabet’s artificial intelligence research laboratory, and to that point, it had kept outside investors at bay. Isomorphic wasn’t even actively raising money. ...
Isomorphic was built around a single piece of technology, a protein modeling tool called AlphaFold. ..."
"Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.'s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort. ..."
"... London-based Isomorphic Labs was formed in 2021 out of DeepMind with the goal of commercializing the lab's breakthrough AlphaFold protein-folding model. It competes with an array of businesses trying to apply the latest AI advances to medicine. ..."
"... At Isomorphic Labs, we spent the last half decade building on this advancement and taking it further, creating the Isomorphic Labs Drug Design Engine (IsoDDE). IsoDDE goes beyond structure prediction, to a system with a suite of predictive capabilities that can accelerate the design and pre-clinical development of unique molecules. Our engine continues to exceed all existing deep-learning models and industry-standard computational methods for designing molecules to date. ..."
Isomorphic Labs (company website)
No comments:
Post a Comment